Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-539P (RNA, U6 small nuclear 539, pseudogene) is a non-coding RNA pseudogene that is related to the U6 small nuclear RNA (snRNA) family[1][2]. U6 snRNA plays a critical role in splicing of pre-mRNA by being a core component of the spliceosomal complex[5]. However, RNU6-539P is classified as a pseudogene, which means it is a genomic copy that resembles the functional U6 snRNA gene but does not produce a functional product[6][7]. Pseudogenes like RNU6-539P arise by gene duplication or retrotransposition and generally lack functional roles in splicing, acting as "genomic fossils" or, occasionally, as regulators of their parental gene via RNA-based mechanisms[6]. There is no evidence that RNU6-539P encodes a protein, functions in RNA processing, or acts as a drug target. Consequently, it is not considered a therapeutic target, biomarker, or gene with well-established biological or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 539, pseudogene (RNU6-539P).